News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Boehringer Ingelheim Corporation (JOBS) to Buy Japanese Consumer-Drug Producer SSP for $913 Million
February 10, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Bloomberg -- Boehringer Ingelheim GmbH agreed to buy the rest of Japan’s SSP Co., a producer of over-the-counter drugs, for about 82 billion yen ($913 million) to expand in the world’s second-biggest pharmaceutical market.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
MORE ON THIS TOPIC
Autoimmune disease
Sanofi Joins With EVOQ in $500M Autoimmune Alliance
October 16, 2025
·
2 min read
·
Tristan Manalac
Rare diseases
Novo Offers up to $2.1B for Omeros’ Complement Drug To Expand Rare Disease Work
October 15, 2025
·
2 min read
·
Dan Samorodnitsky
ALS
BMS Deepens ALS Alliance With Insitro, Puts $2B+ On the Line
October 15, 2025
·
1 min read
·
Tristan Manalac
Mergers & acquisitions
BioCryst Snaps Up Fellow Angiodema Player Astria for $700M
October 15, 2025
·
2 min read
·
Tristan Manalac